Latham & Watkins advised Orbital Therapeutics on the deal. Orbital Therapeutics, which aims to enhance global health by unleashing the full potential of RNA medicine, announced...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Medallion in the financing. Medallion, the modern provider management platform, has announced US$35 million in Series C funding, raising its total funding...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Genascence in the transaction. Genascence Corporation (Genascence), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, has completed...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Solvvy in the transaction while Cooley advised Zoom Video Communications. Zoom Video Communications, Inc. (NASDAQ: ZM) has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom advised Scopely on the deal, while Latham & Watkins advised Sony Pictures. Scopely, one of the largest privately held mobile-first...
You must be a Standard 1 Year member to access this content.
